Skip to main content

Drugs

Ausgabe 1/2021

Inhalt (14 Artikel)

Editorial

50 Years On Still Relevant

Graeme Avery

Editorial

50 Years of Drugs

Dene C. Peters

Leading Article

TRPV1-Targeted Drugs in Development for Human Pain Conditions

Mircea Iftinca, Manon Defaye, Christophe Altier

Review Article

Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing

Danielle Dixon, Michael Edmonds

Open Access Review Article

Therapeutic Options in Hereditary Optic Neuropathies

Giulia Amore, Martina Romagnoli, Michele Carbonelli, Piero Barboni, Valerio Carelli, Chiara La Morgia

Open Access Review Article

Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Diego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M. Huber

Review Article

Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy

Nicola Specchio, Alessandro Ferretti, Marina Trivisano, Nicola Pietrafusa, Chiara Pepi, Costanza Calabrese, Susanna Livadiotti, Alessandra Simonetti, Paolo Rossi, Paolo Curatolo, Federico Vigevano

Systematic Review

Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update

Kirk E. Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R. Covvey, Alyssa M. Peckham, Megan D. Morrison

AdisInsight Report

Enarodustat: First Approval

Anthony Markham

AdisInsight Report

REGN-EB3: First Approval

Anthony Markham

Open Access Correction

Correction to: Decitabine/Cedazuridine: First Approval

Sohita Dhillon

Open Access Correction

Correction to: Selpercatinib: First Approval

Anthony Markham

Aktuelle Ausgaben